{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:12Z","timestamp":1787995032075,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10067-026-08325-2","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:09:05Z","timestamp":1785481745000},"page":"5553-5562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of leflunomide with tumor necrosis factor inhibitors in psoriatic arthritis: a retrospective analysis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-9519","authenticated-orcid":false,"given":"\u0130brahim Yahya","family":"\u00c7ak\u0131r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-4660","authenticated-orcid":false,"given":"Emre","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-5683","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"Firlatan-Yazgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8757-6226","authenticated-orcid":false,"given":"Mustafa","family":"Ekici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2345-346X","authenticated-orcid":false,"given":"G\u00f6zde Sevgi Kart","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4381-202X","authenticated-orcid":false,"given":"Erdin\u00e7","family":"\u00dcnald\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-9114","authenticated-orcid":false,"given":"G\u00fcl Sandal","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-9619","authenticated-orcid":false,"given":"Gizem","family":"Ayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3274-3258","authenticated-orcid":false,"given":"Zehra","family":"\u00d6zsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1064-9690","authenticated-orcid":false,"given":"Levent","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-3117","authenticated-orcid":false,"given":"\u00d6mer","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-9144","authenticated-orcid":false,"given":"Ali","family":"Akdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8208-1585","authenticated-orcid":false,"given":"\u015eule Apra\u015f","family":"Bilgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3904-0769","authenticated-orcid":false,"given":"Ali \u0130hsan","family":"Ertenli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-2109","authenticated-orcid":false,"given":"Umut","family":"Kalyoncu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-6061","authenticated-orcid":false,"given":"Sedat","family":"Kiraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"Suppl 2","key":"8325_CR1","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14-17","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8325_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69(1):48\u201353","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8325_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11926-015-0517-0","volume":"17","author":"LC Coates","year":"2015","unstructured":"Coates LC, Helliwell PS (2015) Treat to target in psoriatic arthritis\u2014evidence, target, research agenda. Curr Rheumatol Rep 17(6):517","journal-title":"Curr Rheumatol Rep"},{"issue":"6 Suppl 1","key":"8325_CR4","first-page":"52","volume":"49","author":"LC Coates","year":"2021","unstructured":"Coates LC, Corp N, van der Windt DA et al (2021) GRAPPA treatment recommendations: 2021 update. J Rheumatol 49(6 Suppl 1):52\u201354","journal-title":"J Rheumatol"},{"issue":"6","key":"8325_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/ard-2024-225531","volume":"83","author":"L Gossec","year":"2023","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJO et al (2023) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis 83(6):706\u2013719","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8325_CR6","volume":"2016","author":"GS Hazlewood","year":"2016","unstructured":"Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe DJA, Bombardier C (2016) Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: a network meta-analysis. Cochrane Database Syst Rev 2016(8):CD010227","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"8325_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41584-018-0064-y","volume":"14","author":"BN Cronstein","year":"2018","unstructured":"Cronstein BN (2018) Methotrexate BAFFles anti-drug antibodies. Nat Rev Rheumatol 14(9):505\u2013506","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"8325_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/art.40851","volume":"71","author":"PJ Mease","year":"2019","unstructured":"Mease PJ, Gladman DD, Collier DH et al (2019) Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial. Arthritis Rheumatol 71(7):1112\u20131124","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8325_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/annrheumdis-2012-202347","volume":"73","author":"KM Fagerli","year":"2014","unstructured":"Fagerli KM, Lie E, van der Heijde D et al (2014) The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study. Ann Rheum Dis 73(1):132\u2013137","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8325_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000181","volume":"1","author":"PJ Mease","year":"2015","unstructured":"Mease PJ, Collier DH, Saunders KC, Li G, Kremer JM, Greenberg JD (2015) Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry. RMD Open 1(1):e000181","journal-title":"RMD Open"},{"issue":"3","key":"8325_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3899\/jrheum.141596","volume":"43","author":"F Behrens","year":"2016","unstructured":"Behrens F, Koehm M, Arndt U et al (2016) Does concomitant methotrexate with adalimumab influence treatment outcomes in patients with psoriatic arthritis? Data from a large observational study. J Rheumatol 43(3):632\u2013639","journal-title":"J Rheumatol"},{"issue":"1","key":"8325_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003423","volume":"10","author":"PJ Mease","year":"2024","unstructured":"Mease PJ, Reddy S, Ross S et al (2024) Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis. RMD Open 10(1):e003423","journal-title":"RMD Open"},{"issue":"6","key":"8325_CR13","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/art.20253","volume":"50","author":"JP Kaltwasser","year":"2004","unstructured":"Kaltwasser JP, Nash P, Gladman D et al (2004) Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 50(6):1939\u20131950","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8325_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/acr.21848","volume":"65","author":"F Behrens","year":"2013","unstructured":"Behrens F, Finkenwirth C, Pavelka K et al (2013) Leflunomide in psoriatic arthritis: results from a large European prospective observational study. Arthritis Care Res (Hoboken) 65(3):464\u2013470","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"8325_CR15","first-page":"728","volume":"32","author":"A Asiri","year":"2014","unstructured":"Asiri A, Thavaneswaran A, Kalman-Lamb G, Chandran V, Gladman DD (2014) The effectiveness of leflunomide in psoriatic arthritis. Clin Exp Rheumatol 32(5):728\u2013731","journal-title":"Clin Exp Rheumatol"},{"key":"8325_CR16","first-page":"21","volume":"71","author":"PLCM van Riel","year":"2004","unstructured":"van Riel PLCM, Smolen JS, Emery P et al (2004) Leflunomide: a manageable safety profile. J Rheumatol Suppl 71:21\u201324","journal-title":"J Rheumatol Suppl"},{"issue":"4","key":"8325_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2710.2000.00296.x","volume":"25","author":"PJ Hewitson","year":"2000","unstructured":"Hewitson PJ, Debroe S, McBride A, Milne R (2000) Leflunomide and rheumatoid arthritis: a systematic review of effectiveness, safety and cost implications. J Clin Pharm Ther 25(4):295\u2013302","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"8325_CR18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.55563\/clinexprheumatol\/jhpymv","volume":"39","author":"G Kimyon","year":"2021","unstructured":"Kimyon G, Kalyoncu U, Kiraz S et al (2021) Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data. Clin Exp Rheumatol 39(4):852\u2013858","journal-title":"Clin Exp Rheumatol"},{"issue":"521","key":"8325_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","volume":"113","author":"F Li","year":"2018","unstructured":"Li F, Morgan KL, Zaslavsky AM (2018) Balancing covariates via propensity score weighting. J Am Stat Assoc 113(521):390\u2013400","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"8325_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14926","volume":"34","author":"Y Xie","year":"2021","unstructured":"Xie Y, Liu Y, Liu Y (2021) Are biologics combined with methotrexate better than biologics monotherapy in psoriasis and psoriatic arthritis: a meta-analysis of randomized controlled trials. Dermatol Ther 34(3):e14926","journal-title":"Dermatol Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08325-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:35:52Z","timestamp":1787992552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8325"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08325-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Hacettepe University Non-Interventional Research Ethics Committee (approval date, 15 November 2022; Decision No. 2022\/19\u201339; Registration No. GO 22\/754). All procedures were in accordance with institutional and national ethical standards.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed consent was waived by the Ethics Committee due to the retrospective design and use of anonymized patient data.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":3,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}